You are viewing: Italy Home Healthcare Market analysis
Part of: Home Healthcare Market (Global)

The Italy Home Healthcare Market was valued at $8068.69 Million in 2025 and projected to reach to $11551.41 Million by 2030, representing a compound annual growth rate of CAGR 7.4%. Italy's home healthcare market is positioned for sustained growth driven by demographic pressures and evolving healthcare preferences.

Italy Home Healthcare Market Trends and Insights

  • This growth trajectory reflects Italy's aging demographic profile and increasing preference for in-home care solutions over institutional settings.
  • Italy's healthcare system is increasingly recognizing home healthcare as a cost-effective alternative that improves patient outcomes and quality of life. The Italian home healthcare sector is driven by demographic shifts, with Italy maintaining one of Europe's oldest populations.
  • Italy's healthcare infrastructure is adapting to support expanded home-based services, including nursing care, rehabilitation, and chronic disease management.
  • Between 2025 and 2030, Italy is expected to see significant investment in home healthcare technologies and workforce development to meet rising demand. Italy's market growth is supported by government initiatives promoting aging-in-place policies and reimbursement models favoring home care delivery.
  • Italy's regional healthcare systems are increasingly integrating home healthcare into primary care networks, enhancing accessibility and coordination of care across the country..

Key Market Statistics

  • CAGR (2025-2030) CAGR 7.4%
  • Market Size, 2025 ~USD 8068.69 Million
  • Forecast, 2030 ~USD 11551.41 Million
  • Country Italy

Italy Home Healthcare Market Overview

Aging Population Driving Demand :

Italy has one of Europe's oldest populations, with over 23% aged 65+. This demographic shift is significantly increasing demand for home healthcare services as families seek cost-effective alternatives to institutional care facilities.

Strong Market Valuation :

Italy's home healthcare market is valued at $8,068.69 million in 2025, with projections reaching $11,551.41 million by 2030, demonstrating robust growth potential and investor confidence in the sector.

Healthcare System Integration :

Italy's public healthcare system is increasingly recognizing and integrating home healthcare services, improving reimbursement policies and regulatory frameworks that support market expansion and service accessibility.

Consistent Growth Trajectory :

With a CAGR of 7.4% through 2030, Italy's home healthcare market outperforms many European counterparts, reflecting strong adoption rates and favorable conditions for service providers and technology innovators.

Italy Home Healthcare Market Dynamics

  • The country's aging population, combined with rising healthcare costs and patient preference for in-home care, creates a favorable environment for market expansion.
  • Government initiatives to shift care delivery from hospitals to community-based settings are accelerating adoption rates. The forecast period through 2030 will likely see increased investment in digital health solutions, caregiver training programs, and integrated care models.
  • Regional disparities between northern and southern Italy may present both challenges and opportunities for market penetration.
  • Healthcare providers and technology companies entering the Italian market should prioritize regulatory compliance and partnerships with local healthcare authorities..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Italy's home healthcare market will grow from $8,068.69M (2025) to $11,551.41M (2030) at a 7.4% CAGR.
    • Italy's aging population and preference for in-home care are primary drivers of market expansion.
    • Italy's government policies supporting aging-in-place are accelerating home healthcare adoption.
    • Italy's regional healthcare systems are integrating home care into primary care networks to improve care coordination.

    Home Healthcare Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment INSULIN DELIVERY DEVICES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.9% from 2025 to 2030
    Largest Segment THERAPEUTIC PRODUCTS (Product)
    Market Size Base Year (Billions) ~USD 309.35 (2025)
    Revenue Forecast (Billions) ~USD 473.8 (2030)
    Segments Covered Product, Type, Product & Service

    Italy Home Healthcare Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Mobility Care Products
    • Testing, Screening, & Monitoring Products
    • Testing, Screening, And Monitoring Products
    • Therapeutic Products

    By Type

    • Activity Monitors & Wrist Bands
    • Blood Glucose Monitors
    • Blood Pressure Monitors
    • Cancer
    • Canes
    • Cardiovascular Diseases & Hypertension
    • Cardiovascular Disorders & Hypertension
    • Cholesterol Testing Products
    • Coagulation Monitoring Products
    • Colon Cancer Test Kits
    • Crutches
    • Diabetes
    • Dialysis Equipment
    • Drug & Alcohol Test Kits
    • Ecg/Ekg Devices
    • Eeg Devices
    • Fetal Monitoring Devices
    • Hearing Aids
    • Hearing Disorders
    • Heart Rate Monitors
    • Hiv Test Kits
    • Holter & Event Monitors
    • Home Hba1C Test Kits
    • Home Hemoglobin A1C Test Kits
    • Home Sleep Testing Devices
    • Hospice & Palliative Care Services
    • Hospice And Palliative Care Services
    • Infusion Therapy Services
    • Inhalers
    • Insulin Delivery Devices
    • Iv Equipment
    • Mobility Disorders
    • Mobility Scooters
    • Nebulizers
    • Other Indications
    • Other Therapeutic Products
    • Ovulation & Pregnancy Test Kits
    • Oxygen Delivery Systems
    • Peak Flow Meters
    • Pregnancy
    • Pregnancy Care Services
    • Pulse Oximeters
    • Rehabilitation Therapy Services
    • Respiratory Diseases
    • Respiratory Therapy Services
    • Skilled Nursing Services
    • Sleep Apnea Therapeutic Devices
    • Temperature Monitoring Devices
    • Unskilled Care Services
    • Ventilators
    • Walkers & Rollators
    • Wheelchairs
    • Wound Care
    • Wound Care Products

    By Product & Service

    • Product
    • Service

    Target Audience

    • Healthcare Providers & Operators : Home healthcare agencies and service providers need Italy-specific market data to assess expansion opportunities, benchmark performance, and develop localized service strategies in this growing market.
    • Medical Device & Technology Companies : Manufacturers of home healthcare equipment and digital health solutions require detailed Italian market insights to identify demand drivers, regulatory pathways, and partnership opportunities with local providers.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Italy's healthcare sector need comprehensive market sizing, growth forecasts, and competitive analysis to make informed investment decisions and assess portfolio potential.
    • Government & Policy Makers : Italian healthcare authorities and policymakers use market research to inform healthcare reform initiatives, budget allocation, and regulatory frameworks that support sustainable home healthcare expansion.
    • Pharmaceutical & Pharmaceutical Services Companies : Pharmaceutical firms and medication management service providers need Italy-specific data to understand home healthcare market dynamics and develop integrated care solutions for aging populations.

    Key Companies in the Italy Home Healthcare Market

    CompanyHQOwnershipStrongest segments
    FISHER & PAYKEL HEALTHCAREUnited StatesPublic CompanyTherapeutic (CPAP, humidification, respiratory support devices),Monitoring, Testing, Screening (OSA and respiratory-related),Mobility Care and accessories,
    NOVO NORDISK A/SDenmarkPublic CompanyTherapeutic (insulins, GLP-1, obesity and rare disease therapies used at home),Testing, Screening, Monitoring (digital dose guidance, data connectivity around pens),Mobility Care,
    APRIA HEALTHCARE GROUP, INCUnited StatesPrivate CompanyTherapeutic (respiratory, sleep apnea, NPWT, other HME),Testing, Screening, Monitoring,Mobility Care and other HME,
    CONMED CORPORATIONUnited StatesPublic CompanyTherapeutic (home-use relevant),Testing, Screening, Monitoring,Mobility Care,
    CONSORT MEDICALUnited KingdomPrivate CompanyTherapeutic (drug delivery devices for home use),Testing, Screening & Monitoring–linked devices,Mobility Care–adjacent components,
    HENRY SCHEINUnited StatesPublic CompanyTherapeutic products for home use,Testing, screening, and monitoring,Mobility care and durable equipment,
    HILL-ROM HOLDINGS, INC.United StatesPrivate CompanyTherapeutic (incl. respiratory and non-invasive therapeutic surfaces),Mobility Care (beds, lifts, patient mobility solutions for home),Testing, Screening & Monitoring,
    JABILUnited StatesPublic CompanyTherapeutic devices (home-use),Testing, Screening & Monitoring devices,Mobility care hardware,
    ROSSMAX INTERNATIONAL LTDTaiwanPublic CompanyMonitoring (BP monitors, thermometers, oximeters, scales),Therapeutic & Respiratory (nebulizers, suction units, aero spacers, heating pads, anti-decubitus mattresses),Testing & Screening (blood glucose systems, peak flow meters),
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyTherapeutic (home dialysis equipment, solutions, consumables),Testing, Screening, Monitoring,Mobility Care,
    ABBOTTUnited StatesPublic CompanyTesting, Screening, and Monitoring,Therapeutic,Mobility Care,
    LINDE PLCUnited KingdomPublic CompanyTherapeutic (home oxygen, respiratory support),Testing, Screening, Monitoring,Mobility Care,
    RESMEDUnited StatesPublic CompanyTherapeutic (home respiratory and sleep therapy devices),Testing & Screening (home sleep diagnostics),Monitoring (remote patient monitoring and analytics),
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyTherapeutic (incl. sleep and respiratory care, home ventilation),Testing, Screening, Monitoring (remote patient monitoring, diagnostics at home),Mobility Care and Personal Health Devices,
    GE HEALTHCAREUnited StatesPublic CompanyMonitoring (vital signs, diagnostic cardiology, maternal-infant),Testing, Screening & Imaging-linked Home Pathways,Therapeutic & Infusion-linked Solutions,
    A&D HOLON HOLDINGS COMPANY, LIMITEDJapanPublic CompanyTesting, Screening, and Monitoring Devices,Therapeutic Devices (Ultrasonic Inhalers),Mobility Care,
    CONVATEC GROUP PLCUnited KingdomPublic CompanyTherapeutic products (wound, ostomy, continence, infusion sets) used at home,Monitoring / testing interfaces linked to infusion and chronic care,Mobility and home-care accessories for chronic-condition management,
    AMEDISYSUnited StatesPrivate CompanyTherapeutic (home-based therapies, including infusion support),Testing, Screening, Monitoring (clinical assessments, remote oversight),Mobility Care (rehabilitation, PT/OT, functional support),
    INVACARE CORPORATIONUnited StatesPrivate CompanyMobility Care (power and manual wheelchairs, ramps),Therapeutic & Lifestyle (pressure-relief, beds, safe patient handling),Testing, Screening & Monitoring (heart rate monitors, thermometers),
    SUNRISE MEDICALUnited StatesPrivate CompanyMobility Care (manual & power wheelchairs, scooters),Therapeutic & Rehabilitation Products (seating, positioning),Testing, Screening, Monitoring & Other,

    FISHER & PAYKEL HEALTHCARE

    Fisher & Paykel Healthcare is a publicly traded medical device company founded in 1934 and headquartered in the United States. With 7,396 employees, the company designs and manufactures healthcare products and systems.

    NOVO NORDISK A/S

    Novo Nordisk A/S is a Danish pharmaceutical company founded in 1923 and publicly listed on stock exchanges. The company employs 67,900 people and focuses on biopharmaceutical research and development.

    APRIA HEALTHCARE GROUP, INC

    Appia Healthcare Group, Inc. is a privately held U.S. healthcare company founded in 2018 with 6,250 employees. The company provides healthcare services and solutions to patients and providers.

    CONMED CORPORATION

    CONMED Corporation is a publicly traded medical technology company founded in 1970 and based in the United States. With 3,900 employees, the company manufactures surgical and patient monitoring equipment.

    CONSORT MEDICAL

    Consort Medical is a privately held British medical device company founded in 1938 with 2,000 employees. The company develops and manufactures drug delivery and diagnostic devices.

    HENRY SCHEIN

    Henry Schein is a publicly traded healthcare company founded in 1932 and headquartered in the United States. With 25,000 employees, the company distributes medical, dental, and veterinary products and services.

    HILL-ROM HOLDINGS, INC.

    Hill-Rom Holdings, Inc. is a privately held medical technology company founded in 1915 and based in the United States. The company employs 10,000 people and manufactures patient care equipment and solutions.

    JABIL

    Jabil is a publicly traded electronics manufacturing services company founded in 1966 with 135,000 employees. The company provides design, engineering, and manufacturing services across multiple industries including healthcare.

    ROSSMAX INTERNATIONAL LTD

    Rossmax International Ltd. is a publicly traded Taiwanese medical device company founded in 1988. The company manufactures and distributes healthcare monitoring and diagnostic equipment.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a publicly traded German healthcare company founded in 1996 with 108,165 employees. The company provides dialysis products, services, and healthcare solutions globally.

    ABBOTT

    Abbott is a publicly traded American healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, medical devices, diagnostics, and nutritional products.

    LINDE PLC

    Linde PLC is a publicly traded British industrial gases and healthcare company founded in 1879 with 65,034 employees. The company supplies gases, equipment, and services to healthcare and other industries.

    RESMED

    ResMed is a publicly traded medical device company founded in 1989 and headquartered in the United States. With 10,600 employees, the company manufactures cloud-connected medical devices for respiratory care and patient monitoring.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a publicly traded Dutch technology company founded in 1891 with 64,317 employees. The company manufactures healthcare equipment, consumer electronics, and lighting solutions.

    GE HEALTHCARE

    GE Healthcare is a publicly traded American healthcare technology company founded in 2022 with 54,000 employees. The company provides medical imaging, monitoring, and diagnostic equipment and services.

    A&D HOLON HOLDINGS COMPANY, LIMITED

    A&D Holon Holdings Company, Limited is a publicly traded Japanese medical device company founded in 1977 with 2,480 employees. The company manufactures and distributes healthcare monitoring and diagnostic equipment.

    CONVATEC GROUP PLC

    ConvaTec Group PLC is a publicly traded British medical technology company founded in 1978 with 10,910 employees. The company manufactures ostomy care, continence care, and wound care products.

    AMEDISYS

    Amedisys is a privately held American healthcare company founded in 1982 with 19,000 employees. The company provides home health, hospice, and personal care services.

    INVACARE CORPORATION

    Invacare Corporation is a privately held American medical device company founded in 1885 with 2,800 employees. The company manufactures mobility and respiratory care products for patients.

    SUNRISE MEDICAL

    Sunrise Medical is a privately held American medical device company founded in 1978 with 4,470 employees. The company manufactures and distributes mobility and accessibility products for patients.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation figures for Italy's home healthcare market ($8.07B in 2025) with detailed forecasts through 2030, enabling accurate financial planning and investment decisions specific to the Italian market.
    • Demographic Insights : Understand Italy's unique aging demographic profile and its direct impact on home healthcare demand, helping stakeholders identify high-opportunity segments and tailor service offerings to local population needs.
    • Competitive Landscape Analysis : Gain intelligence on market dynamics, key players, and competitive positioning within Italy's home healthcare sector to inform market entry strategies and competitive differentiation approaches.
    • Regulatory & Reimbursement Framework : Obtain detailed analysis of Italy's healthcare system integration, reimbursement policies, and regulatory environment to navigate compliance requirements and identify funding opportunities for home healthcare providers.
    • Strategic Growth Opportunities : Identify emerging trends, regional variations, and untapped market segments within Italy to develop targeted expansion strategies and capitalize on the 7.4% CAGR growth opportunity through 2030.

    Frequently asked questions

    What is the projected market size of home healthcare in Italy by 2030?

    Italy's home healthcare market is projected to reach $11,551.41 million by 2030, up from $8,068.69 million in 2025.

    What is the CAGR for Italy's home healthcare market?

    Italy's home healthcare market is expected to grow at a compound annual growth rate of 7.4% between 2025 and 2030.

    What factors are driving growth in Italy's home healthcare market?

    Italy's aging demographic profile, government aging-in-place policies, cost-effectiveness of home care, and integration into primary care networks are key growth drivers.

    How is Italy's healthcare system supporting home healthcare expansion?

    Italy's regional healthcare systems are investing in home healthcare technologies, workforce development, and reimbursement models that favor home-based care delivery.

    Why is home healthcare becoming more popular in Italy?

    Italy's patients increasingly prefer in-home care for improved quality of life, cost savings, and better health outcomes compared to institutional care settings.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global home healthcare market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the home healthcare market. The primary sources from the demand side include home healthcare service providers and home users. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Home Healthcare Market

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global home healthcare market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global home healthcare market was split into various segments and sub-segments based on:

    • List of major players operating in the product market at the regional and/or country level
    • Product mapping of home healthcare providers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from home healthcare (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global home healthcare market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach & Top-down Approach)

    Home Healthcare Market

    Data Triangulation

    After arriving at the overall size of the global home healthcare market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Home healthcare refers to the medical attention, care, and support provided to patients at their residences by licensed healthcare workers, such as nurses, home health aides, and personal care aides. The home healthcare market includes products and services that can be set up remotely at a patient’s home.

    Stakeholders

    • Home Healthcare Equipment Manufacturers
    • Home Healthcare Service Providers
    • Home Health Software Vendors
    • Nursing Service Providers
    • Wound Care Product Manufacturers
    • Pregnancy Care Product Manufacturers and Service Providers
    • Supportive Care Product Manufacturers and Service Providers
    • Diagnostic Companies
    • Research & Development (R&D) Companies
    • Business Research and Consulting Service Providers
    • Medical Research Laboratories
    • Venture Capitalists

    Report Objectives

    • To define, describe, segment, and forecast the global home healthcare market by product, service, indication, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall home healthcare market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC Countries
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as acquisitions, product launches & approvals, and expansions
    • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Get the Full Home Healthcare Market Report

    Full forecast, segment splits, and company analysis for all Home Healthcare Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status